A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring
Sponsor study identifier
interventional
19
1 country
1
Study Start
May 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2012
Actual (reported)Study Completion
October 2012
Actual (reported)This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment, Physicians assessment score and Patients self assessment score.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2012
Date type not reportedThis date has not been verified as actual or estimated.
July 17, 2012
Actual (reported)July 19, 2012
Actual (reported)October 2012
Actual (reported)October 2012
Actual (reported)Changes in the Global Acne scarring classification
Day 0, End of study - Month 3
Photographic Assessment
Day 0, Month 1, Month 2 End of study - Month 3
Physician's assessment scores
End of Study - Month 3
Patient's assessment scores
End of Study - Month 3
Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring
Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring.
Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring
Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring
Kasiak Research Pvt Ltd
Thane, Maharashtra, 400610, India
Sharmila Patil, Dr.
Dermocosmetic laser center hair and skin clinic
Pankaj Maniar, Dr.
Radiance Cosmetology Clinique
19 participants (actual enrollment reported by the registry).
First Submitted
July 17, 2012
First Posted
July 19, 2012
Study Start
May 2012
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 2012
Actual (reported)Study Completion
October 2012
Actual (reported)Last Updated
October 15, 2012
Record last verified: 2012-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: